In the CC, the comment was made that mgt had 3 potential first in class drugs moving along nicely in clinical trials (or something close to that). Since Dr B and Leo have access to real time trial data and the trials are so far along at this point in time with interim results being known, I do not believe they would be making those statements unless the data is showing very strong results for all products. If data was marginal or poor, they could be looked at as misleading investors and I know they are too professional to put themselves in that position.

Wonder how many real investors sold today. Cannot feel sorry for those that did since they knew 10 July is just around the corner.